We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£129.99
It has never been this cheap. We have no record of a lower price.
£130 today · cheaper than every other day in the last 3 months
Springer Early Phase Cancer Immunotherapy - Current Cancer Research
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 71 days · 71 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 71 days • 1 price levels
Price Analysis
Most common price: £130 (71 days, 100.0%)
Price range: £130 - £130
Price levels: 1 different prices over 71 days
Description
Key Features
Early phase clinical trials for cancer immunotherapy are thoroughly reviewed with focus on translating laboratory discoveries into effective patient treatments.
Biomarker selection strategies help identify which patients are most likely to respond to specific cancer immunotherapy approaches.
Combinatorial immunotherapy strategies and their safety profiles are examined to optimise treatment efficacy and manage toxicity.
Phase 2 dosing determination methods provide practical guidance for establishing safe and effective treatment protocols in early phase trials.
Radiographic pseudoprogression evaluation endpoints address the unique imaging challenges that arise when assessing cancer immunotherapy response.
Histology selection and patient stratification techniques help maximise the relevance of early phase trial findings to diverse cancer populations.
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 3319876287
- Domain
- Amazon UK
- Release Date
- 28 August 2018
- Listed Since
- 31 August 2018
Barcode
No barcode data available
Similar Products You Might Like
Cancer Immunotherapy: Paradigms, Practice and Promise - Springer
Springer
Progress in Cancer Immunotherapy: 909 (Advances in Experimental Medicine and Biology, 909)
Springer
Cancer Immunotherapy: Methods and Protocols: 2748 (Methods in Molecular Biology, 2748)
Humana
Immunotherapy of Cancer (Volume 128) (Advances in Cancer Research, Volume 128)
Elsevier
Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
Springer
Cancer Immunotherapy (Advances in Immunology): Volume 90
Elsevier
Immunotherapy of Cancer (Cancer Drug Discovery and Development)
Humana
Immunotherapy of Cancer (Cancer Drug Discovery and Development)
Humana
Immunotherapy of Cancer: Innovative Treatment Comes of Age
Springer
Critical Developments in Cancer Immunotherapy
Tumor Immunology and Cancer Therapy - CRC Press
CRC Press
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
Springer
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
Springer
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
Springer
Oncoimmunology: A Practical Guide for Cancer Immunotherapy
Springer
T Cell Cancer Immunotherapies - Drug Discovery Guide
Humana
Developments in T Cell Based Cancer Immunotherapies (Cancer Drug Discovery and Development)
Humana
Animal Models for Cancer Immunotherapy Development - Wiley
Wiley
Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
Springer
Tumor Immunology: Immunotherapy and Cancer Vaccines
Cambridge University Press
Immunotherapy: 1342 (Advances in Experimental Medicine and Biology, 1342)
Springer
Cancer Chemotherapy, Immunotherapy, and Biotherapy
Lippincott Williams & Wilkins
Immunotherapy in Translational Cancer Research (Translational Oncology)
Wiley
Cancer Immunotherapy Meets Oncology: In Honor of Christoph Huber
Springer